Yat Sun Or is Sr. VP, R&D & CSO of Enanta Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ENANTA PHARMACEUTICALS INC
22 Nov 23
4
ENANTA PHARMACEUTICALS INC
17 Mar 23
4
ENANTA PHARMACEUTICALS INC
15 Feb 23
4
ENANTA PHARMACEUTICALS INC
5 Dec 22
4
ENANTA PHARMACEUTICALS INC
28 Nov 22
4
ENANTA PHARMACEUTICALS INC
15 Feb 22
4
ENANTA PHARMACEUTICALS INC
3 Dec 21
4
ENANTA PHARMACEUTICALS INC
23 Nov 21
4
ENANTA PHARMACEUTICALS INC
28 Jan 21
4
ENANTA PHARMACEUTICALS INC
16 Dec 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Nov 23 | ENTA Enanta Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 8.99 | 86,000 | 773.14 k | 86,000 |
15 Mar 23 | ENTA Enanta Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 44.46 | 13,656 | 607.15 k | 374,702 |
15 Mar 23 | ENTA Enanta Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 43.92 | 269 | 11.81 k | 388,358 |
15 Mar 23 | ENTA Enanta Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 14 | 13,925 | 194.95 k | 388,627 |
15 Mar 23 | ENTA Enanta Pharmaceuticals | Stock Option Common Stock | Option exercise | Dispose M | No | No | 14 | 13,925 | 194.95 k | 0 |
13 Feb 23 | ENTA Enanta Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 52.77 | 7,752 | 409.07 k | 374,702 |
13 Feb 23 | ENTA Enanta Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 13,017 | 0.00 | 382,454 |
13 Feb 23 | ENTA Enanta Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 10,250 | 0.00 | 369,437 |
1 Dec 22 | ENTA Enanta Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 44.33 | 1,055 | 46.77 k | 359,187 |
23 Nov 22 | ENTA Enanta Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 21,000 | 0.00 | 360,242 |